10%–20% of CVID cases are explained by mutations in one of a number of genes including lipopolysaccharide‐responsive and beige‐like anchor (LRBA; OMIM #614700; Eren Akarcan et al., 2018; Hou et al., 2017). This evidence concerns the gene LRBA and common variable immunodeficiency.